- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0022522

About Maximon Pharma Private Limited
Data last updated:
Maximon Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2018PTC335210. Its GSTIN is 07AALCM9162F1Z6 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sarita Kapur and Harshavardhan Karunakar Hegde.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 512 And 513 Fifth Floor Plot No. 6, Pragati Devika Tower Nehru Place South Delhi – 110019, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.55 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹18.45 Lakh (net margin 11.9%) and EBITDA of ₹12.13 Lakh (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 18% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Maximon Pharma.
Maximon Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0022522). For more details, the company can be reached via its website maximonwellness.com.
Company details
Recognitions & Rankings of Maximon Pharma
Contact details
Maximon Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is maximonwellness.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo. 512 And 513 Fifth Floor Plot No. 6, Pragati Devika Tower Nehru Place South Delhi – 110019, New Delhi, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Maximon Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Maximon Pharma operates one associated brand: Maximon Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supplies and exports pharmaceutical products, medicines, and health supplements globally. | maximonwellness.com |
Business activity
The main business activity of Maximon Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maximon Pharma Private Limited, buy the company report.
Financials of Maximon Pharma Private Limited
FY 2025 filings availableMaximon Pharma Private Limited reported revenue of ₹1.55 Cr (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 30% growth in the latest year. EBITDA rose 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 11.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maximon Pharma Private Limited, buy the company report.
Board of directors of Maximon Pharma Private Limited
Maximon Pharma has 6 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarita Kapur Also directs: Rico Auto Industries Limited, SMC Global Securities Limited | Director | 01 Aug 2021 | 5 Years 3 Months | Current |
| Harshavardhan Karunakar Hegde Also directs: Team Ortho Private Limited, Nutralodge Private Limited, Labnow Solutions Private Limited and 2 more | Director | 12 Jun 2018 | 8 Years 5 Months | Current |
| Akshay Kumar Saxena Also directs: Nutralodge Private Limited, Universal Critical Care LLP | Director | 12 Jun 2018 | 8 Years 5 Months | Current |
| Anjali Harshavardhan Hegde Also directs: Team Ortho Private Limited | Director | 01 Aug 2021 | 5 Years 3 Months | Current |
| Rakesh Mattoo Also directs: Nutralodge Private Limited | Director | 12 Jun 2018 | 8 Years 5 Months | Current |
| Arundhati Hegde Also directs: Iomprecision International LLP | Director | 01 Aug 2021 | 5 Years 3 Months | Current |
Peer comparison
Maximon Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asteroids Healthcare Private Limited | ₹1.56 Cr (FY 2024) | 5.0% | Jaipur, Rajasthan, India | |||
| Relife Drugs Private Limited | ₹1.55 Cr (FY 2025) | 21.0% | Lucknow, Uttar Pradesh, India | |||
| Maximon Pharma Private Limitedthis company | ₹1.55 Cr (FY 2025) | ₹18.45 Lakh | 11.9% | 30.0% | 6 | New Delhi, Delhi, India |
| Inowell Pharma Private Limited | ₹1.55 Cr (FY 2025) | 33.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Maximon Pharma Private Limited, buy the company report.
Auditor
Maximon Pharma Private Limited is audited by KUMAR VERMA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMAR VERMA & ASSOCIATES | FY 2023 | 004872N |
Shareholding
The shareholding of Maximon Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Maximon Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Maximon Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maximon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maximon Pharma Private Limited has a workforce of 6 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 6 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Maximon Pharma Private Limited, buy the company report.
GST
Maximon Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCM9162F1Z6 | Delhi | Active | 16 Apr 2019 |
To see the full GST registrations and return filing status of Maximon Pharma Private Limited, buy the company report.
Recent activity
Maximon Pharma Private Limited has 9 board changes on record since 2018: 6 appointments and 3 cessations. The latest: Anjali Harshavardhan Hegde ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Maximon Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 June 2018 (8+ years old) and is registered under CIN U74900DL2018PTC335210.
Maximon Pharma has 6 current directors:
- Sarita Kapur - Director
- Harshavardhan Karunakar Hegde - Director
- Akshay Kumar Saxena - Director
- Anjali Harshavardhan Hegde - Director
- Rakesh Mattoo - Director
- Arundhati Hegde - Director
The latest financial statements of Maximon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Maximon Pharma is 07AALCM9162F1Z6, registered in Delhi.
The CIN (Corporate Identification Number) of Maximon Pharma is U74900DL2018PTC335210. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maximon Pharma was incorporated on 12 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Maximon Pharma by revenue are Asteroids Healthcare Private Limited, Relife Drugs Private Limited, Inowell Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Anjali Harshavardhan Hegde ceased to be Additional Director on 30 Nov 2021. Arundhati Hegde ceased to be Additional Director on 30 Nov 2021. Sarita Kapur ceased to be Additional Director on 30 Nov 2021. Maximon Pharma has 9 board changes on record in total.
Yes, Maximon Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0022522).
Maximon Pharma can be reached through the website maximonwellness.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Maximon Pharma is at No. 512 And 513 Fifth Floor Plot No. 6, Pragati Devika Tower Nehru Place South Delhi – 110019, New Delhi, Delhi, India – 110019.

